video

Source: CBS Detroit

(CBS DETROIT) – Henry Ford Health System is defending its hydroxychloroquine study showing the drug does help lower the death rates among Covid-19 patients.

The study comes after Dr. Anthony Fauci criticized it as “flawed” casting doubt on the results.

Officials at Henry Ford Health acknowledge the politicization of the drug has become an obstacle to studying its effects and the best treatment for Covid-19.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »